Global Congestive Heart Failure Registry
Global Congestive Heart Failure Registry
Heart failure (HF) is a major health problem worldwide but there is no global HF study that
 documents demographics, socioeconomic and clinical factors, diagnostic and management
 patterns, etiology, biomarkers, co-morbidities, treatments, quality of life, barriers to care
 and outcomes in all parts of the world. Such knowledge is essential in the prevention and
 treatment of this global disease. The Global Congestive Heart Failure Registry (G-CHF) is a
 global registry of approximately 20,000-25,000 HF patients enrolled over approximately 5
 years to study these risks and causes of HF.
The G-CHF Registry is a prospective global cohort study of approximately 20,000-25,000 HF
 patients enrolled over approximately 5 years. Baseline data will be obtained on demographic
 and socioeconomic data, clinical and laboratory variables, co-morbidities, biomarkers,
 echocardiography, HF causes, medication use, management patterns, quality of life, and health
 systems. Six-month, 12-month, 18-month and 24-month follow-up data will be obtained to
 document patient outcomes and factors associated with outcomes.

 A sub-study of approximately 4000 patients (a subset of the main study population) will be
 performed to measure frailty, cognitive and lung function, mental health, medication
 adherence, patient-reported barriers to care, dietary assessment, and collection of blood and
 urine samples for central storage and analysis.
Inclusion Criteria:

 -  Patients ≥ 18 years of age with a clinical diagnosis of HF seen in outpatient clinics
 or inpatient hospital wards of the participating centres.

 -  Written informed consent

 Exclusion Criteria:

 -  Patients considered unreliable by the investigator concerning the requirements for
 follow-up visits.